Oct 22 | Apr 22 | Oct 21 | Apr 21 | Oct 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | $ 788.00K | $ 35.00K | $ 52.00K | $ 66.00K | $ 49.00K |
Total Assets | $ 20.52M | $ 20.26M | $ 20.93M | $ 20.93M | $ 20.35M |
Total Debt | $ 2.41M | $ ― | $ 5.22M | $ ― | $ 5.83M |
Net Debt | $ 1.63M | $ ― | $ 5.16M | $ ― | $ 5.78M |
Total Liabilities | $ 5.10M | $ 5.98M | $ 7.46M | $ 8.29M | $ 7.65M |
Stockholders Equity | $ 15.43M | $ 14.28M | $ 13.46M | $ 12.64M | $ 12.70M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |